Convatec launches ‘Accelerate’ strategy with upgraded growth and margin targets

An update from ConvaTec ( (GB:CTEC) ) is now available.

Convatec has unveiled a new ‘Accelerate’ strategy at its Capital Markets Day, positioning it as the next phase of growth following its previous FISBE programme, which helped establish the company as a chronic care leader. The framework is built around four pillars, emphasising customer-focused growth, a stronger innovation pipeline with digital and AI tools, improved execution, and a performance-driven culture.

The group tied this strategy to upgraded medium-term financial targets, including 6–8% annual organic revenue growth, higher growth across all major business categories and a 24–26% adjusted operating margin. Management signalled expectations for double-digit growth in adjusted earnings per share and free cash flow, underscoring confidence that structural demand trends in chronic care and a strengthened product pipeline will support sustainable and profitable expansion.

The most recent analyst rating on (GB:CTEC) stock is a Buy with a £259.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.

Spark’s Take on CTEC Stock

According to Spark, TipRanks’ AI Analyst, CTEC is a Neutral.

The score is driven primarily by solid underlying financial performance (growth, improving operating margins, positive free cash flow) and supportive guidance for continued growth and margin expansion. This is tempered by increased leverage and notable operational/regulatory risks flagged on the call, while valuation looks expensive and technicals appear near overbought despite an uptrend.

To see Spark’s full report on CTEC stock, click here.

More about ConvaTec

Convatec Group is a medical products and technology company focused on chronic-care solutions across advanced wound care, ostomy care, continence care and infusion care. The group develops and sells differentiated products and services to patients, healthcare professionals and payers, with a growing presence across key global markets where ageing populations and rising chronic conditions support long-term demand.

Average Trading Volume: 9,465,861

Technical Sentiment Signal: Sell

Current Market Cap: £4.18B

See more data about CTEC stock on TipRanks’ Stock Analysis page.